BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 708208)

  • 1. [Antimycotic agents. 7. Nuclear substituted N-(1-adamantyl)-N'-phenylthiourea derivatives].
    Kreutzberger A; Tantawy A
    Arch Pharm (Weinheim); 1978 Sep; 311(9):770-4. PubMed ID: 708208
    [No Abstract]   [Full Text] [Related]  

  • 2. [Antiviral agents. 6. Variation of substituents in the series of N'-substituted N-(adamantyl-(1))-thioureas].
    Kreutzberger A; Schröders HH
    Arch Pharm (Weinheim); 1975 Oct; 308(10):748-54. PubMed ID: 1200790
    [No Abstract]   [Full Text] [Related]  

  • 3. [Antiviral agents. 22. N-aliphatic, N-alicyclic and N-polycyclic substituted N'-(2-adamantyl)ureas and -thioureas].
    Kreutzberger A; Tantawy A
    Arzneimittelforschung; 1983; 33(4):512-4. PubMed ID: 6683528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biologically active polycycloalkanes. 1. Antiviral adamantane derivatives.
    Aigami K; Inamoto Y; Takaishi N; Hattori K; Takatsuki A
    J Med Chem; 1975 Jul; 18(7):713-21. PubMed ID: 1171241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. General synthesis of potentially antiviral alpha-adamantyl carbonyl compounds.
    Reetz MT; Maier WF; Schwellnus K; Chatziiosifidis I
    Angew Chem Int Ed Engl; 1979 Jan; 18(1):72. PubMed ID: 105650
    [No Abstract]   [Full Text] [Related]  

  • 6. [Synthesis and in vitro virucidal effect of recent 1-substituted adamantane derivatives].
    Sztaricskai F; Pelyvás I; Dinya Z; Szilágyi L; Györgydeák Z; Hadházy G; Váczi L; Bognár R
    Pharmazie; 1975 Sep; 30(9):571-81. PubMed ID: 1187737
    [No Abstract]   [Full Text] [Related]  

  • 7. 2-Adamantyl- and 2-adamantylidene-2-ethylamines.
    Mariani E; Schenone P
    Farmaco Sci; 1976 Apr; 31(4):272-6. PubMed ID: 939326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphorus-nitrogen compounds. 21. Murine oncolytic and antifertility effect of adamantylaziridine compounds.
    Cates LA; Cramer MB; Williams L
    J Med Chem; 1978 Jan; 21(1):143-6. PubMed ID: 619145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Synthesis and the action of adamantane derivatives on the Sindbis virus].
    Danilenko GI; Vladimirtsev IF; Iurchenko AG; Galegov GA; Leont'eva NO
    Farm Zh; 1976; 31(5):36-40. PubMed ID: 1026489
    [No Abstract]   [Full Text] [Related]  

  • 10. [Phosphoric esters of adamantanols, adamantanethiols, adamantyl alcohols and their alkyl derivatives, I: Synthese of the phosphoric esters of reaction with 2-chloro-1,3-dioxa-2-phosphorindane-2-oxide (author's transl)].
    Böhringer H; Vogt H
    Arch Pharm (Weinheim); 1977 Nov; 310(11):894-905. PubMed ID: 931578
    [No Abstract]   [Full Text] [Related]  

  • 11. [Search for anticholinergic agents. III. Synthesis of various adamantane derivatives].
    Woliński J; Kordonowska B; Plachta D
    Acta Pol Pharm; 1977; 34(1):17-22. PubMed ID: 848315
    [No Abstract]   [Full Text] [Related]  

  • 12. [Synthesis of virostatically acting N[adamantyl-(1)]-carbonic acid amides].
    Kretzberger VA; Schröders HH
    Arzneimittelforschung; 1975 Mar; 25(3):333-8. PubMed ID: 1174028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, antimicrobial, and anti-inflammatory activities of novel 2-(1-adamantyl)-5-substituted-1,3,4-oxadiazoles and 2-(1-adamantylamino)-5-substituted-1,3,4-thiadiazoles.
    Kadi AA; El-Brollosy NR; Al-Deeb OA; Habib EE; Ibrahim TM; El-Emam AA
    Eur J Med Chem; 2007 Feb; 42(2):235-42. PubMed ID: 17129641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adamantane and protoadamantanealkanamines as potential anti-Parkinson agents.
    Chakrabarti JK; Hotten TM; Sutton S; Tupper DE
    J Med Chem; 1976 Jul; 19(7):967-9. PubMed ID: 940116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [1-adamantanecarboxamide derivatives with potential antiviral and antineoplastic activity].
    Fenech G; Vigorita MG; Ficarra P; Ficarra R
    Boll Chim Farm; 1979 Feb; 118(2):78-87. PubMed ID: 454536
    [No Abstract]   [Full Text] [Related]  

  • 16. [Synthesis and virostatic activity of adamantan-1-carbonic acid amidines (author's transl)].
    May G; Peteri D; Hummel K
    Arzneimittelforschung; 1978; 28(5):732-5. PubMed ID: 581952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antiviral agents/4th communication: the aromatically substituted carbonic acid amide structure in potentically virustatic compounds (author's transl)].
    Kreutzberger A; Schröders HH
    Arzneimittelforschung; 1975 Jul; 25(7):994-7. PubMed ID: 1174415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antiviral agents, XI: Nucleophilic substitutions and additions with 2-aminoadamantane (author's transl)].
    Kreutzberger A; Schröders HH
    Arch Pharm (Weinheim); 1976 Nov; 309(11):919-25. PubMed ID: 1016004
    [No Abstract]   [Full Text] [Related]  

  • 19. [Synthesis of 1,3-disubstituted adamantanes (author's transl)].
    Fischer W; Grob CA; Katayama H
    Helv Chim Acta; 1976 Sep; 59(6):1949-62. PubMed ID: 1017951
    [No Abstract]   [Full Text] [Related]  

  • 20. Hypobetalipoproteinemic agents. 2. Compounds related to 4-(1-adamantyloxy)aniline.
    Lednicer D; Heyd WE; Emmert DE; TenBrink RE; Schurr PE; Day CE
    J Med Chem; 1979 Jan; 22(1):69-77. PubMed ID: 218007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.